Search / Trial NCT06222463

Power Dissipation in Flow-controlled Ventilation

Launched by MEDICAL UNIVERSITY INNSBRUCK · Jan 16, 2024

Trial Information

Current as of October 07, 2024

Recruiting

Keywords

Flow Controlled Ventilation Power Dissipation Mechanical Power

Description

After anesthesia induction and securing the airway with a tracheal tube, tha patients will be ventilated with flow-controlled ventilation (FCV) using standard of low tidal volume ventilation with a positive end-expiratory pressure (PEEP) of 5 cmH2O and the peak pressure set to achieve a tidal volume of 7 ml/kg predicted body weight. I:E ration will be set to 1:1, the gas flow adjusted to achieve normocapnia and the fraction of inspired oxygen adjusted to achieve normoxia. After opening the abdominal cavity baseline parameters will be recorded and subsequently the study participant randomize...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Male and female subjects ≥ 18 years
  • * Body weight ≥ 40 kg
  • * Elective open abdominal surgery under general anaesthesia - American Society of Anesthesiologists Classification I-III
  • * Written informed consent
  • Exclusion Criteria:
  • * Emergency surgery
  • * American Society of Anesthesiologists Classification IV-V
  • * Female subjects known to be pregnant
  • * Known participation in another interventional clinical trial

About Medical University Innsbruck

The Medical University of Innsbruck is a leading academic institution dedicated to advancing healthcare through innovative research and clinical excellence. Situated in the heart of the Austrian Alps, it combines a rich tradition of medical education with cutting-edge scientific inquiry. As a prominent sponsor of clinical trials, the university focuses on a broad spectrum of medical fields, emphasizing the translation of research findings into practical applications for patient care. With a commitment to ethical standards and rigorous methodologies, the Medical University of Innsbruck strives to enhance treatment options and improve health outcomes globally through its collaborative efforts in clinical research.

Locations

Innsbruck, Tyrol, Austria

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0